Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
CorMedix Inc (CRMD) had Stock-Based Compensation of $3.50M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$39.08M |
|
$20.64M |
|
$1.60M |
|
$37.48M |
|
$18.96M |
|
$20.13M |
|
$0.52M |
|
$20.64M |
|
$20.64M |
|
$20.64M |
|
$20.64M |
|
$20.64M |
|
$20.64M |
|
$20.13M |
|
$20.33M |
|
65.24M |
|
68.97M |
|
$0.32 |
|
$0.30 |
|
| Balance Sheet Financials | |
$144.86M |
|
$1.73M |
|
$4.72M |
|
$149.58M |
|
$34.39M |
|
-- |
|
$0.30M |
|
$34.69M |
|
$114.89M |
|
$113.10M |
|
$114.89M |
|
67.71M |
|
| Cash Flow Statement Financials | |
$19.74M |
|
$-0.19M |
|
$6.09M |
|
$40.76M |
|
$66.39M |
|
$25.63M |
|
|
Stock-Based Compensation |
$3.50M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
95.91% |
|
51.50% |
|
51.50% |
|
-- |
|
52.82% |
|
52.82% |
|
$19.73M |
|
-- |
|
-- |
|
-- |
|
0.26 |
|
0.21 |
|
0.72 |
|
125.76 |
|
17.97% |
|
18.25% |
|
13.80% |
|
17.97% |
|
$1.70 |
|
$0.29 |
|
$0.29 |
|